Product Information
LIDOCAINE HCL 2% VIAL is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0762 per ML under NDC 31722021733. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on Nov 8, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
20 mg/mL
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722021733
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA214336FDA Approved
11/8/2021
TE Code
AP
On Market Since
11/8/2021
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 2% VIAL has been published 100 times since Nov 6, 2024, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0762 per ML |
|---|---|
| All-time high | $0.1139 (Nov 13, 2024) |
| All-time low | $0.0762 (Sep 23, 2026) |
| 52-week high | $0.0902 |
| 52-week low | $0.0762 |
| Median price | $0.0853 |
| Average price | $0.0866 |
| Largest weekly change | -12.7% (Nov 20, 2024) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 2% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 2% VIAL, manufactured by Camber Pharmaceuticals Inc., is $0.0762 per ML (NDC 31722021733), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 2% VIAL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 2% VIAL has declined 33.1%. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 2% VIAL?
Since Nov 6, 2024, the NADAC for LIDOCAINE HCL 2% VIAL has ranged from a low of $0.0762 (Sep 23, 2026) to a high of $0.1139 (Nov 13, 2024), with a median of $0.0853 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 2% VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIDOCAINE HCL 2% VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures LIDOCAINE HCL 2% VIAL?
LIDOCAINE HCL 2% VIAL (NDC 31722021733) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.